Doug Breaks a Double-Blind Study
Doug gives a sample drug to an ailing patient and jeopardizes grants.
In Plain English
The case is double-blind study tampering.
What Happened in the Episode
Double Blind directly supports clinical trial tampering.
Clinical Concept
Double-Blind Study Tampering
What ER Teams Would Evaluate
A real team would evaluate double-blind study tampering using the supported presentation, vital signs, focused history, exam, risk assessment, and targeted consultation or testing when indicated.
Treatment and Management Overview
Management depends on severity and may include stabilization, symptom control, specialist consultation, documentation, safety planning, and follow-up.
What TV Gets Right
The episode summary supports this as a concrete medical, safety, diagnostic, or care-pathway thread.
What TV Compresses
The available summary does not support adding unshown vital signs, test results, medication doses, timestamps, consent dialogue, or final outcomes.
Sources and Further Reading
- iDRief catalog page
- TVmaze - ER 5x12 Double Blind
- Local iDRief episode catalog summary
- TVmaze - ER 5x12 Double BlindEPISODE
Supports: Supports the episode summary used for this case.
- AMA Code of Medical Ethics - Informed ConsentTIER 4
Supports: Supports informed consent and patient communication principles.
- HHS - The HIPAA Privacy RuleTIER 4
Supports: Supports health-information privacy context.
- HHS - The Belmont ReportTIER 4
Supports: Supports human-subjects research ethics.
- iDRief catalog pageEPISODE
Supports: Supports episode-level evidence for this curated case.